REDMILE GROUP, LLC – Kymera Therapeutics, Inc. Transaction History
REDMILE GROUP, LLC portfolio value:
$62.62M
portfolio value
REDMILE GROUP, LLC quarter portfolio value change:
+10.56%
quarter
Kymera Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +10.34% | 269.50K shares | 11.29M | $21.77 | 2.87M |
| Q2 2022 | share | Decrease | -0.30% | -7.9K shares | -59.33M | $19.69 | 2.60M |
| Q1 2022 | share | Increase | +1.05% | 27.3K shares | -53.62M | $42.32 | 2.61M |
| Q4 2021 | share | Decrease | -7.37% | -205.97K shares | 193K | $62.98 | 2.58M |
| Q3 2021 | share | Increase | +10.36% | 262.2K shares | 41.32M | $58.74 | 2.79M |
| Q2 2021 | share | Decrease | -2.75% | -71.63K shares | 21.62M | $48.5 | 2.53M |
| Q1 2021 | share | Decrease | -4.31% | -117.35K shares | -67.51M | $38.86 | 2.60M |
| Q4 2020 | share | Decrease | -0.45% | -12.17K shares | 80.37M | $62 | 2.72M |
| Q3 2020 | share | Increase | 0.00% | 2.73M shares | 88.29M | $32.31 | 2.73M |